Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Myeloid, Acute | 18 | 2024 | 3646 | 0.930 |
Why?
|
Gene Expression Regulation, Neoplastic | 16 | 2024 | 8611 | 0.610 |
Why?
|
Neuroblastoma | 6 | 2024 | 1263 | 0.580 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2023 | 385 | 0.570 |
Why?
|
Principal Component Analysis | 4 | 2008 | 951 | 0.540 |
Why?
|
DNA, Mitochondrial | 3 | 2008 | 869 | 0.450 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 5 | 2022 | 104 | 0.440 |
Why?
|
RNA-Binding Protein EWS | 6 | 2022 | 212 | 0.440 |
Why?
|
Bone Neoplasms | 6 | 2022 | 2567 | 0.410 |
Why?
|
Glycogen Synthase Kinase 3 | 4 | 2022 | 414 | 0.390 |
Why?
|
Gene Expression Profiling | 13 | 2017 | 9525 | 0.340 |
Why?
|
Xenograft Model Antitumor Assays | 13 | 2021 | 3608 | 0.330 |
Why?
|
Cyclin-Dependent Kinase 4 | 3 | 2018 | 561 | 0.310 |
Why?
|
Neoplasm Proteins | 6 | 2018 | 3596 | 0.310 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2022 | 1608 | 0.280 |
Why?
|
Cell Line, Tumor | 22 | 2024 | 17075 | 0.270 |
Why?
|
Oligonucleotide Array Sequence Analysis | 7 | 2015 | 3797 | 0.270 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2021 | 5337 | 0.250 |
Why?
|
Creatine Kinase | 2 | 2018 | 682 | 0.250 |
Why?
|
I-kappa B Kinase | 2 | 2018 | 248 | 0.250 |
Why?
|
Proto-Oncogene Proteins c-myc | 4 | 2020 | 995 | 0.240 |
Why?
|
Drug Synergism | 5 | 2019 | 1749 | 0.230 |
Why?
|
Lymphoma, Follicular | 2 | 2005 | 459 | 0.220 |
Why?
|
Folic Acid | 2 | 2021 | 1338 | 0.220 |
Why?
|
Breast Neoplasms | 8 | 2014 | 21056 | 0.210 |
Why?
|
Sulfonamides | 3 | 2024 | 1984 | 0.210 |
Why?
|
Longevity | 2 | 2008 | 1087 | 0.200 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2023 | 173 | 0.200 |
Why?
|
Lymphoma, B-Cell | 2 | 2006 | 943 | 0.190 |
Why?
|
Cystine | 1 | 2022 | 96 | 0.190 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2024 | 479 | 0.190 |
Why?
|
Gangliosides | 1 | 2022 | 132 | 0.190 |
Why?
|
Phylogeny | 2 | 2008 | 2832 | 0.190 |
Why?
|
Glycine Hydroxymethyltransferase | 1 | 2021 | 34 | 0.190 |
Why?
|
Enzyme Inhibitors | 3 | 2023 | 3715 | 0.180 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2007 | 698 | 0.180 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 634 | 0.180 |
Why?
|
Cluster Analysis | 4 | 2008 | 2721 | 0.180 |
Why?
|
Indazoles | 2 | 2019 | 303 | 0.170 |
Why?
|
Immunologic Memory | 3 | 2017 | 1375 | 0.170 |
Why?
|
Lymphocytes | 1 | 2007 | 2599 | 0.170 |
Why?
|
Meta-Analysis as Topic | 1 | 2005 | 1370 | 0.160 |
Why?
|
U937 Cells | 5 | 2020 | 259 | 0.160 |
Why?
|
Gene Amplification | 3 | 2024 | 1091 | 0.160 |
Why?
|
Protein Kinase Inhibitors | 8 | 2023 | 5696 | 0.160 |
Why?
|
Gene Expression Regulation, Leukemic | 3 | 2019 | 657 | 0.160 |
Why?
|
Aminopyridines | 3 | 2019 | 576 | 0.160 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 3 | 2006 | 1434 | 0.160 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2020 | 276 | 0.160 |
Why?
|
Homeodomain Proteins | 3 | 2021 | 2428 | 0.160 |
Why?
|
Cell Proliferation | 13 | 2021 | 10429 | 0.160 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2019 | 121 | 0.160 |
Why?
|
Azepines | 2 | 2018 | 327 | 0.160 |
Why?
|
Y-Box-Binding Protein 1 | 1 | 2018 | 41 | 0.160 |
Why?
|
Signal Transduction | 14 | 2022 | 23601 | 0.150 |
Why?
|
Bepridil | 1 | 2018 | 12 | 0.150 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2018 | 352 | 0.150 |
Why?
|
HMGB Proteins | 1 | 2017 | 45 | 0.140 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2022 | 691 | 0.140 |
Why?
|
Yellow Fever Vaccine | 1 | 2017 | 38 | 0.140 |
Why?
|
Phenylenediamines | 1 | 2018 | 89 | 0.140 |
Why?
|
Mice | 25 | 2024 | 81819 | 0.140 |
Why?
|
Trans-Activators | 2 | 2024 | 2850 | 0.140 |
Why?
|
Bone Marrow | 2 | 2019 | 2921 | 0.140 |
Why?
|
Receptor, erbB-2 | 1 | 2007 | 2593 | 0.140 |
Why?
|
Integrin beta3 | 2 | 2017 | 120 | 0.140 |
Why?
|
Glioblastoma | 2 | 2010 | 3459 | 0.140 |
Why?
|
Cell Death | 2 | 2019 | 1679 | 0.140 |
Why?
|
Methenyltetrahydrofolate Cyclohydrolase | 1 | 2016 | 10 | 0.130 |
Why?
|
Small Molecule Libraries | 2 | 2019 | 741 | 0.130 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2017 | 4642 | 0.130 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2015 | 2844 | 0.130 |
Why?
|
Animals | 33 | 2024 | 168764 | 0.130 |
Why?
|
Receptor, IGF Type 1 | 1 | 2018 | 385 | 0.130 |
Why?
|
Humans | 73 | 2024 | 765968 | 0.130 |
Why?
|
Proto-Oncogenes | 1 | 2017 | 320 | 0.130 |
Why?
|
Molecular Targeted Therapy | 5 | 2020 | 2822 | 0.130 |
Why?
|
Cell Cycle Proteins | 5 | 2021 | 3430 | 0.130 |
Why?
|
Proteomics | 4 | 2022 | 3910 | 0.120 |
Why?
|
Clone Cells | 1 | 2019 | 1672 | 0.120 |
Why?
|
Triazoles | 2 | 2018 | 897 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2015 | 2423 | 0.120 |
Why?
|
Cell Differentiation | 5 | 2017 | 11641 | 0.120 |
Why?
|
Citric Acid Cycle | 1 | 2016 | 228 | 0.120 |
Why?
|
Mice, Inbred NOD | 4 | 2021 | 1837 | 0.120 |
Why?
|
Epigenesis, Genetic | 3 | 2018 | 3819 | 0.120 |
Why?
|
Receptor, Notch1 | 1 | 2018 | 517 | 0.120 |
Why?
|
Haplotypes | 4 | 2012 | 2728 | 0.120 |
Why?
|
Genomics | 3 | 2014 | 5929 | 0.120 |
Why?
|
Calcium Channel Blockers | 1 | 2018 | 686 | 0.120 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2016 | 1167 | 0.120 |
Why?
|
Up-Regulation | 4 | 2017 | 4137 | 0.120 |
Why?
|
Methotrexate | 1 | 2021 | 1722 | 0.120 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 350 | 0.120 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2015 | 2880 | 0.120 |
Why?
|
Wnt Proteins | 1 | 2018 | 722 | 0.120 |
Why?
|
HMGN1 Protein | 1 | 2014 | 27 | 0.110 |
Why?
|
Neoplasms | 6 | 2020 | 22340 | 0.110 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2018 | 660 | 0.110 |
Why?
|
Lymphocytic choriomeningitis virus | 2 | 2013 | 175 | 0.110 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2015 | 164 | 0.110 |
Why?
|
Chemokine CCL5 | 1 | 2014 | 213 | 0.110 |
Why?
|
Genome, Human | 4 | 2018 | 4448 | 0.110 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 182 | 0.110 |
Why?
|
Proteome | 1 | 2004 | 1899 | 0.110 |
Why?
|
RNA Interference | 4 | 2018 | 2832 | 0.110 |
Why?
|
High-Throughput Screening Assays | 2 | 2019 | 938 | 0.110 |
Why?
|
Chromosome Mapping | 2 | 2016 | 4618 | 0.110 |
Why?
|
Cyclin D1 | 1 | 2015 | 449 | 0.110 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 13648 | 0.110 |
Why?
|
Genomic Instability | 1 | 2017 | 718 | 0.100 |
Why?
|
Purines | 1 | 2016 | 615 | 0.100 |
Why?
|
Gene Duplication | 1 | 2014 | 317 | 0.100 |
Why?
|
Lactase | 1 | 2012 | 72 | 0.100 |
Why?
|
T-Lymphocytes | 5 | 2023 | 10261 | 0.100 |
Why?
|
Ribonucleoproteins | 1 | 2014 | 359 | 0.100 |
Why?
|
Transcription Factors | 3 | 2017 | 12131 | 0.100 |
Why?
|
RNA, Neoplasm | 1 | 2014 | 745 | 0.100 |
Why?
|
Embryo, Nonmammalian | 1 | 2015 | 907 | 0.090 |
Why?
|
Arenaviridae Infections | 1 | 2011 | 53 | 0.090 |
Why?
|
DNA Methylation | 5 | 2024 | 4424 | 0.090 |
Why?
|
Pyrimidines | 3 | 2018 | 3047 | 0.090 |
Why?
|
Nuclear Proteins | 4 | 2022 | 5783 | 0.090 |
Why?
|
Genetic Markers | 2 | 2008 | 2601 | 0.090 |
Why?
|
Apoptosis | 7 | 2024 | 9514 | 0.090 |
Why?
|
Brain Neoplasms | 2 | 2010 | 9071 | 0.090 |
Why?
|
Mice, Nude | 4 | 2019 | 3618 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2014 | 497 | 0.090 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2015 | 777 | 0.080 |
Why?
|
Hematopoiesis | 2 | 2019 | 2058 | 0.080 |
Why?
|
HL-60 Cells | 3 | 2016 | 364 | 0.080 |
Why?
|
Histones | 2 | 2024 | 2584 | 0.080 |
Why?
|
Lysine | 1 | 2014 | 991 | 0.080 |
Why?
|
RNA, Messenger | 5 | 2015 | 12768 | 0.080 |
Why?
|
Neoplasm Invasiveness | 2 | 2007 | 3602 | 0.080 |
Why?
|
MicroRNAs | 3 | 2017 | 3785 | 0.080 |
Why?
|
Pan paniscus | 1 | 2008 | 5 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2018 | 2942 | 0.080 |
Why?
|
Vital Capacity | 1 | 2012 | 995 | 0.080 |
Why?
|
Myelodysplastic Syndromes | 1 | 2019 | 1404 | 0.080 |
Why?
|
Myeloproliferative Disorders | 1 | 2015 | 616 | 0.080 |
Why?
|
Oncogene Proteins | 1 | 2013 | 710 | 0.080 |
Why?
|
Mutation | 10 | 2023 | 30198 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4392 | 0.080 |
Why?
|
Carrier Proteins | 1 | 2021 | 4913 | 0.070 |
Why?
|
Pan troglodytes | 1 | 2008 | 224 | 0.070 |
Why?
|
Antigen Presentation | 1 | 2013 | 1250 | 0.070 |
Why?
|
Benzamides | 3 | 2019 | 1377 | 0.070 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2010 | 368 | 0.070 |
Why?
|
Genes, erbB-1 | 1 | 2008 | 161 | 0.070 |
Why?
|
DNA Modification Methylases | 1 | 2008 | 207 | 0.070 |
Why?
|
Computer Simulation | 4 | 2017 | 6255 | 0.070 |
Why?
|
Drug Discovery | 1 | 2015 | 1064 | 0.070 |
Why?
|
Databases, Nucleic Acid | 1 | 2008 | 204 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2056 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9373 | 0.070 |
Why?
|
Gene Dosage | 2 | 2010 | 1216 | 0.070 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 1560 | 0.070 |
Why?
|
Cell Survival | 4 | 2021 | 5747 | 0.070 |
Why?
|
Neurofibromin 1 | 1 | 2008 | 190 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2004 | 4900 | 0.070 |
Why?
|
Carcinoma, Ductal | 1 | 2007 | 97 | 0.070 |
Why?
|
Zebrafish | 4 | 2021 | 3036 | 0.070 |
Why?
|
Exercise Tolerance | 1 | 2012 | 841 | 0.070 |
Why?
|
Transforming Growth Factor beta | 2 | 2019 | 1995 | 0.070 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1646 | 0.070 |
Why?
|
DNA Repair Enzymes | 1 | 2008 | 342 | 0.070 |
Why?
|
RNA, Small Interfering | 4 | 2018 | 3421 | 0.070 |
Why?
|
Genes, erbB-2 | 1 | 2007 | 160 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2016 | 16047 | 0.070 |
Why?
|
Dipeptides | 2 | 2018 | 387 | 0.060 |
Why?
|
Japan | 2 | 2008 | 1415 | 0.060 |
Why?
|
Phosphorylation | 4 | 2019 | 8278 | 0.060 |
Why?
|
DNA Repair | 2 | 2021 | 2048 | 0.060 |
Why?
|
Protein Structure, Tertiary | 2 | 2013 | 3750 | 0.060 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2019 | 1679 | 0.060 |
Why?
|
Emigration and Immigration | 1 | 2008 | 405 | 0.060 |
Why?
|
Logic | 1 | 2005 | 38 | 0.060 |
Why?
|
Diet, Gluten-Free | 1 | 2008 | 285 | 0.060 |
Why?
|
Receptors, Immunologic | 1 | 2011 | 1415 | 0.060 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2005 | 136 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2018 | 2878 | 0.060 |
Why?
|
Promoter Regions, Genetic | 4 | 2021 | 5786 | 0.060 |
Why?
|
Neurofibromatosis 1 | 1 | 2010 | 560 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 2 | 2010 | 3181 | 0.060 |
Why?
|
Discriminant Analysis | 1 | 2005 | 222 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2014 | 3222 | 0.060 |
Why?
|
Multigene Family | 1 | 2007 | 1080 | 0.060 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2021 | 647 | 0.060 |
Why?
|
Computational Biology | 2 | 2007 | 3559 | 0.060 |
Why?
|
Down-Regulation | 3 | 2018 | 2927 | 0.060 |
Why?
|
Genes, Tumor Suppressor | 1 | 2008 | 1061 | 0.060 |
Why?
|
Female | 21 | 2021 | 396112 | 0.060 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 507 | 0.060 |
Why?
|
Cells | 1 | 2005 | 162 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2006 | 360 | 0.050 |
Why?
|
Mice, SCID | 2 | 2021 | 2630 | 0.050 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2010 | 954 | 0.050 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2006 | 409 | 0.050 |
Why?
|
T-Lymphocyte Subsets | 1 | 2011 | 1811 | 0.050 |
Why?
|
Mesenchymal Stem Cells | 2 | 2018 | 1663 | 0.050 |
Why?
|
Kidney Neoplasms | 2 | 2010 | 4274 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3655 | 0.050 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2024 | 196 | 0.050 |
Why?
|
Cyclin-Dependent Kinase 8 | 1 | 2023 | 48 | 0.050 |
Why?
|
Prognosis | 6 | 2021 | 29922 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2021 | 6113 | 0.050 |
Why?
|
Mice, Inbred C57BL | 6 | 2020 | 22332 | 0.050 |
Why?
|
Pattern Recognition, Automated | 2 | 2007 | 978 | 0.050 |
Why?
|
Dendritic Cells | 1 | 2013 | 2747 | 0.050 |
Why?
|
Histone Acetyltransferases | 1 | 2024 | 332 | 0.050 |
Why?
|
Sequence Alignment | 1 | 2006 | 2171 | 0.050 |
Why?
|
Daunorubicin | 1 | 2022 | 157 | 0.050 |
Why?
|
Databases as Topic | 1 | 2004 | 471 | 0.050 |
Why?
|
Sulfasalazine | 1 | 2022 | 85 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2010 | 4108 | 0.050 |
Why?
|
Prostatic Hyperplasia | 1 | 2006 | 515 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11868 | 0.050 |
Why?
|
Disease Progression | 3 | 2007 | 13632 | 0.050 |
Why?
|
MAP Kinase Signaling System | 2 | 2019 | 1490 | 0.050 |
Why?
|
Animals, Genetically Modified | 2 | 2017 | 1560 | 0.050 |
Why?
|
Acetylation | 1 | 2024 | 1053 | 0.050 |
Why?
|
POU Domain Factors | 1 | 2021 | 47 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4562 | 0.050 |
Why?
|
Calibration | 1 | 2004 | 814 | 0.050 |
Why?
|
Linkage Disequilibrium | 1 | 2006 | 1997 | 0.050 |
Why?
|
Models, Biological | 3 | 2010 | 9443 | 0.050 |
Why?
|
Nucleotides | 1 | 2023 | 451 | 0.050 |
Why?
|
Laboratories | 1 | 2005 | 462 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2021 | 4260 | 0.050 |
Why?
|
Histocompatibility Antigens | 1 | 2022 | 477 | 0.040 |
Why?
|
Antigens, CD | 1 | 2011 | 4025 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2015 | 15398 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4778 | 0.040 |
Why?
|
Databases, Genetic | 1 | 2007 | 1751 | 0.040 |
Why?
|
beta Catenin | 2 | 2018 | 1043 | 0.040 |
Why?
|
Neoplastic Stem Cells | 1 | 2008 | 1352 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4772 | 0.040 |
Why?
|
Biological Evolution | 1 | 2006 | 1072 | 0.040 |
Why?
|
NF-kappa B | 2 | 2022 | 2485 | 0.040 |
Why?
|
Evolution, Molecular | 1 | 2008 | 1889 | 0.040 |
Why?
|
Genome-Wide Association Study | 2 | 2017 | 12807 | 0.040 |
Why?
|
Celiac Disease | 1 | 2008 | 820 | 0.040 |
Why?
|
Diphenylamine | 1 | 2019 | 49 | 0.040 |
Why?
|
Adoptive Transfer | 2 | 2013 | 827 | 0.040 |
Why?
|
Genes, Neoplasm | 2 | 2016 | 370 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 9601 | 0.040 |
Why?
|
Protein Stability | 1 | 2021 | 577 | 0.040 |
Why?
|
Chromatin | 2 | 2024 | 2980 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2022 | 328 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2006 | 2352 | 0.040 |
Why?
|
Ubiquitination | 1 | 2024 | 996 | 0.040 |
Why?
|
Smad2 Protein | 1 | 2019 | 144 | 0.040 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2006 | 1083 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 225 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2020 | 6220 | 0.040 |
Why?
|
Receptors, Estrogen | 1 | 2007 | 2242 | 0.040 |
Why?
|
Models, Molecular | 1 | 2008 | 5379 | 0.040 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2019 | 311 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 798 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2008 | 2796 | 0.040 |
Why?
|
Radioisotope Dilution Technique | 1 | 2017 | 70 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4247 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2019 | 330 | 0.040 |
Why?
|
Yellow fever virus | 1 | 2017 | 23 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 479 | 0.040 |
Why?
|
Blotting, Western | 2 | 2017 | 5020 | 0.040 |
Why?
|
Reproducibility of Results | 4 | 2018 | 20124 | 0.040 |
Why?
|
Polymers | 1 | 2005 | 1621 | 0.040 |
Why?
|
Deuterium | 1 | 2017 | 104 | 0.040 |
Why?
|
Patient Compliance | 1 | 2008 | 2692 | 0.040 |
Why?
|
Algorithms | 4 | 2007 | 14071 | 0.040 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2005 | 1376 | 0.040 |
Why?
|
Yellow Fever | 1 | 2017 | 54 | 0.030 |
Why?
|
Cysteine | 1 | 2022 | 898 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2024 | 1410 | 0.030 |
Why?
|
Karyotyping | 1 | 2019 | 1178 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2019 | 639 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2017 | 59489 | 0.030 |
Why?
|
Adenosine Triphosphatases | 1 | 2021 | 837 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2005 | 1682 | 0.030 |
Why?
|
Half-Life | 1 | 2017 | 644 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2004 | 2194 | 0.030 |
Why?
|
Phenotype | 3 | 2015 | 16721 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2020 | 14448 | 0.030 |
Why?
|
Mitochondria | 2 | 2022 | 3673 | 0.030 |
Why?
|
Transfection | 2 | 2015 | 5743 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2019 | 820 | 0.030 |
Why?
|
Drug Resistance | 1 | 2022 | 1591 | 0.030 |
Why?
|
Peptides, Cyclic | 1 | 2018 | 390 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2021 | 1130 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2007 | 14652 | 0.030 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2021 | 722 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6499 | 0.030 |
Why?
|
Models, Genetic | 1 | 2006 | 3449 | 0.030 |
Why?
|
Decision Support Techniques | 1 | 2006 | 2003 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2019 | 735 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2017 | 790 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2018 | 720 | 0.030 |
Why?
|
Bone Marrow Examination | 1 | 2015 | 155 | 0.030 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2014 | 15 | 0.030 |
Why?
|
Recurrence | 1 | 2007 | 8501 | 0.030 |
Why?
|
Sarcoma | 1 | 2006 | 1802 | 0.030 |
Why?
|
Chemotaxis | 1 | 2018 | 596 | 0.030 |
Why?
|
Genes, ras | 1 | 2017 | 658 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2007 | 22223 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2021 | 1365 | 0.030 |
Why?
|
Base Sequence | 3 | 2013 | 12403 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2019 | 1385 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2018 | 7599 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 2 | 2019 | 3401 | 0.030 |
Why?
|
Thiophenes | 1 | 2018 | 569 | 0.030 |
Why?
|
Artificial Intelligence | 2 | 2007 | 2659 | 0.030 |
Why?
|
Pyrazines | 1 | 2019 | 1204 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2015 | 18973 | 0.030 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2014 | 228 | 0.030 |
Why?
|
Janus Kinases | 1 | 2014 | 253 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 5389 | 0.030 |
Why?
|
Aged | 7 | 2017 | 171117 | 0.030 |
Why?
|
Cell Cycle | 1 | 2021 | 2920 | 0.030 |
Why?
|
Adult | 9 | 2023 | 223044 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2018 | 1718 | 0.030 |
Why?
|
rab3 GTP-Binding Proteins | 1 | 2012 | 28 | 0.030 |
Why?
|
Middle Aged | 8 | 2017 | 223009 | 0.030 |
Why?
|
Quinazolines | 1 | 2019 | 1364 | 0.030 |
Why?
|
Male | 10 | 2020 | 363698 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2014 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 798 | 0.020 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2012 | 117 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2013 | 381 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 561 | 0.020 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2014 | 430 | 0.020 |
Why?
|
Peptides | 1 | 2004 | 4331 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2004 | 3564 | 0.020 |
Why?
|
Child | 5 | 2022 | 80564 | 0.020 |
Why?
|
Transgenes | 1 | 2015 | 1015 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1599 | 0.020 |
Why?
|
Technology, Pharmaceutical | 1 | 2012 | 83 | 0.020 |
Why?
|
Methylation | 1 | 2014 | 1073 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2015 | 1886 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2012 | 380 | 0.020 |
Why?
|
Indoles | 1 | 2019 | 1839 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2014 | 1701 | 0.020 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2012 | 291 | 0.020 |
Why?
|
Models, Statistical | 1 | 2005 | 5089 | 0.020 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2013 | 308 | 0.020 |
Why?
|
Nucleosomes | 1 | 2014 | 494 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2013 | 962 | 0.020 |
Why?
|
Paracrine Communication | 1 | 2011 | 277 | 0.020 |
Why?
|
Cell Line | 2 | 2019 | 15543 | 0.020 |
Why?
|
Software | 1 | 2004 | 4462 | 0.020 |
Why?
|
Kenya | 1 | 2012 | 758 | 0.020 |
Why?
|
Semaphorins | 1 | 2010 | 96 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2015 | 3586 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1885 | 0.020 |
Why?
|
Genome | 1 | 2017 | 1753 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2014 | 1144 | 0.020 |
Why?
|
Cell Movement | 1 | 2021 | 5194 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2014 | 1742 | 0.020 |
Why?
|
Dexamethasone | 1 | 2016 | 1963 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6309 | 0.020 |
Why?
|
Zebrafish Proteins | 1 | 2015 | 1018 | 0.020 |
Why?
|
Fluorouracil | 1 | 2014 | 1648 | 0.020 |
Why?
|
Time Factors | 2 | 2015 | 40065 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2018 | 6832 | 0.020 |
Why?
|
Tanzania | 1 | 2012 | 1407 | 0.020 |
Why?
|
Adolescent | 4 | 2008 | 88835 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2010 | 955 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2011 | 813 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2013 | 17594 | 0.020 |
Why?
|
Metabolomics | 1 | 2017 | 1668 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2012 | 13451 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2019 | 1883 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2012 | 1693 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2010 | 999 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2008 | 522 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2014 | 2034 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2010 | 1984 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4752 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5881 | 0.020 |
Why?
|
Cell Communication | 1 | 2013 | 1660 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 932 | 0.020 |
Why?
|
Viral Vaccines | 1 | 2011 | 597 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2014 | 2729 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2010 | 2266 | 0.020 |
Why?
|
Gene Frequency | 1 | 2012 | 3624 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9249 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2018 | 3946 | 0.010 |
Why?
|
Walking | 1 | 2012 | 1198 | 0.010 |
Why?
|
Software Design | 1 | 2005 | 173 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2005 | 185 | 0.010 |
Why?
|
Dyspnea | 1 | 2012 | 1352 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2012 | 1892 | 0.010 |
Why?
|
Proteins | 1 | 2018 | 5995 | 0.010 |
Why?
|
DNA Primers | 1 | 2008 | 2825 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2008 | 2476 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2012 | 81514 | 0.010 |
Why?
|
Program Evaluation | 1 | 2012 | 2499 | 0.010 |
Why?
|
Cholesterol | 1 | 2012 | 2898 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10729 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2006 | 11083 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2013 | 5501 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10850 | 0.010 |
Why?
|
Genes, p53 | 1 | 2005 | 711 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2012 | 15880 | 0.010 |
Why?
|
Reference Standards | 1 | 2006 | 1013 | 0.010 |
Why?
|
Viral Load | 1 | 2011 | 3386 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2013 | 3454 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11022 | 0.010 |
Why?
|
Acute Disease | 1 | 2011 | 7232 | 0.010 |
Why?
|
Cell Division | 1 | 2008 | 4475 | 0.010 |
Why?
|
Patient Care Team | 1 | 2012 | 2517 | 0.010 |
Why?
|
Molecular Structure | 1 | 2005 | 1885 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2006 | 12976 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12795 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 2005 | 747 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9550 | 0.010 |
Why?
|
Data Collection | 1 | 2008 | 3318 | 0.010 |
Why?
|
Neurons | 1 | 2017 | 9525 | 0.010 |
Why?
|
Protein Kinases | 1 | 2005 | 1611 | 0.010 |
Why?
|
Fibroblasts | 1 | 2008 | 4159 | 0.010 |
Why?
|
Prostate | 1 | 2006 | 1755 | 0.010 |
Why?
|
Comorbidity | 1 | 2012 | 10563 | 0.010 |
Why?
|
Gene Expression | 1 | 2010 | 7584 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 3247 | 0.010 |
Why?
|
Chronic Disease | 1 | 2011 | 9347 | 0.010 |
Why?
|
Cytokines | 1 | 2011 | 7421 | 0.010 |
Why?
|
Risk Factors | 2 | 2015 | 74840 | 0.010 |
Why?
|
Alleles | 1 | 2006 | 6897 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 18071 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2012 | 65188 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2005 | 4520 | 0.010 |
Why?
|
Age Factors | 1 | 2006 | 18380 | 0.010 |
Why?
|
Databases, Factual | 1 | 2005 | 8067 | 0.000 |
Why?
|
Rats | 1 | 2005 | 23707 | 0.000 |
Why?
|
Cohort Studies | 1 | 2010 | 41649 | 0.000 |
Why?
|
Quality of Life | 1 | 2008 | 13462 | 0.000 |
Why?
|
Child, Preschool | 1 | 2008 | 42500 | 0.000 |
Why?
|